Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 12, 2005, Pages 6630-6637

  Zhou, Rao ^a,c,e   Bird, Ian M ^b,c   Dumesic, Daniel A ^a,d   Abbott, David H ^a,b,c  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d Reproductive Medicine and Infertility Associates   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CORTICOSTEROID; CORTICOSTERONE; CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE; HYDROXYPROGESTERONE; PRASTERONE; TESTOSTERONE;

ADRENAL DISEASE; ADRENAL HYPERANDROGENISM; AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOVULATION; ARTICLE; BODY MASS; BODY WEIGHT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; FETUS; FETUS DEVELOPMENT; HORMONE BLOOD LEVEL; HYPERANDROGENISM; MENSTRUAL CYCLE; NONHUMAN; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PRENATAL PERIOD; PRIMATE; PRIORITY JOURNAL; RHESUS MONKEY; TIME;

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ANDROGENS; ANIMALS; AREA UNDER CURVE; DEHYDROEPIANDROSTERONE; DEXAMETHASONE; FEMALE; FETUS; HORMONES; HYPERANDROGENISM; MACACA MULATTA; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; STEROIDS;

ANIMALIA; MACACA MULATTA; PRIMATES;

EID: 28744440837     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-0691     Document Type: Article

References (58)

1. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI 1999 A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84:4006-4011
2. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF 2000 A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85:2434-2438
3. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745-2749
4. Ehrmann DA, Barnes RB, Rosenfield RL 1995 Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16:322-353
5. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800
6. Franks S 1995 Polycystic ovary syndrome. N Engl J Med 333:853-861
7. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR 2004 Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 89:453-462
8. Legro RS, Strauss JF 2002 Molecular progress in infertility: polycystic ovary syndrome. Fertil Steril 78:569-576
9. Zawadzki JK, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications; 377-384
10. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41-47
11. Rosenfield RL 1999 Ovarian and adrenal function in polycystic ovary syndrome. Endocrinol Metab Clin North Am 28:265-293
12. Legro RS, Driscoll D, Strauss 3rd JF, Fox J, Dunaif A 1998 Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 95:14956-14960
13. Nelson-Degrave VL, Wickenheisser JK, Hendricks KL, Asano T, Fujishiro M, Legro RS, Kimball SR, Strauss 3rd JF, McAllister JM 2005 Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome. Mol Endocrinol 19:379-390
14. Wild RA, Umstot ES, Andersen RN, Ranney GB, Givens JR 1983 Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism.AmJ Obstet Gynecol 146:602-606
15. Moran C, Knochenhauer E, Boots LR, Azziz R 1999 Adrenal androgen excess in hyperandrogenism: relation to age and body mass. Fertil Steril 71:671-674
16. Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA 1992 Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 167:1807-1812
17. Yildiz BO, Woods KS, Stanczyk F, Bartolucci A, Azziz R 2004 Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome. J Clin Endocrinol Metab 89:5558-5562
18. Azziz R, Black V, Hines GA, Fox LM, Boots LR 1998 Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 83:2317-2323
19. Carmina E 1997 Prevalence of adrenal androgen excess in PCOS. In: Dewailly D, ed. Androgen excess disorder in women. Philadelphia: Lippincott-Raven;385-393
20. Moran C, Reyna R, Boots LS, Azziz R 2004 Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess. Fertil Steril 81:126-131
21. Abbott DH, Dumesic DA, Eisner JR, Colman RJ, Kemnitz JW 1998 Insights into the development of PCOS from studies of prenatally androgenized female rhesus monkeys. Trends Endocrinol Metab 9:62-67
22. Abbott DH, Dumesic DA, Franks S 2002 Developmental origin of polycystic ovary syndrome-a hypothesis. J Endocrinol 174:1-5
23. Abbott DH, Barnett DK, Bruns CM, Schramm RD, Dumesic DA 2005 Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update 11:357-374
24. Abbott DH, Eisner JR, Colman RJ, Kemnitz JW, Dumesic DA 2002 Prenatal androgen excess programs for PCOS in female rhesus monkeys. In: Chang RJ, Dunaif A, Hiendel J, eds. Polycystic ovary syndrome. New York: Marcel Dekker; 119-133
25. Eisner JR, Barnett MA, Dumesic DA, Abbott DH 2002 Ovarian hyperandrogenism in adult female rhesus monkeys exposed to prenatal androgen excess. Fertil Steril 77:167-172
26. Azziz R. Ehrmann DA, Legro RS, Fereshetian AG, O'Keefe M, Ghazzi MN; PCOS/Troglitazone Study Group 2003 Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome. Fertil Steril 79:932-937
27. Moran C, Azziz R 2001 The role of adrenal cortex in polycystic ovary syndrome. Obstet Gynecol Clin North Am 28:63-75
28. Azziz R, Rafi A, Smith BR, Bradley EL, Zacur HA 1990 On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism. J Clin Endocrinol Metab 70:431-436
29. Goy RW, Robinson JA 1982 Prenatal exposure of rhesus monkeys to patent androgens: morphological, behavioral, and physiological consequences. Banbury Report 11:355-378
30. Goy RW, Kemnitz JW 1983 Early, persistent, and delayed effects of virilizing substances delivered transplacentally to female rhesus fetuses. In: Weiss B, ed. Application of behavioral pharmacology in toxicology. New York: Raven Press; 303-314
31. Resko JA, Buhl AE, Phoenix CH 1987 Treatment of pregnant rhesus macaques with testosterone propionate: observations on its fate in the fetus. Biol Reprod 37:1185-1191
32. Komindr S, Kurtz BR, Stevens MD, Karas JG, Bittle JB, Givens JR 1986 Relative sensitivity and responsivity of serum cortisol and two adrenal androgens to α-adrenocorticotropin-(1-24) in normal and obese, nonhirsute, eumenorrheic women. J Clin Endocrinol Metab 63:860-864
33. Erwin JM, Tigno XT, Gerzanich G, Hansen BC 2004 Age-related changes in fasting plasma cortisol in rhesus monkeys: implications of individual differences for pathological consequences. J Gerontol A Biol Sci Med Sci 59:424-432
34. Gust DA, Wilson ME, Stocker T, Conrad S, Plotsky PM, Gordon TP 2000 Activity of the hypothalamic-pituitary-adrenal axis is altered by aging and exposure to social stress in female rhesus monkeys. J Clin Endocrinol Metab 85:2556-2563
35. Colman RJ, Kemnitz JW, Lane MA, Abbott DH, Binkley N 1999 Skeletal effects of aging and menopausal status in female rhesus macaques. J Clin Endocrinol Metab 84:4144-4148
36. Ibanez L, Bonnin MR, Zampolli M, Prat N, Alia PJ, Navarro MA 1995 Usefulness of an ACTH test in the diagnosis of nonclassical 21-hydroxylase deficiency among children presenting with premature pubarche. Horm Res 44:51-56
37. Urbanski HF, Downs JL, Garyfallou VT, Mattison JA, Lane MA, Roth GS, Ingram DK 2004 Effect of caloric restriction on the 24-hour plasma DHEAS and cortisol profiles of young and old male rhesus macaques. Ann NY Acad Sci 1019:443-447
38. Kemnitz JW, Holston KA, Colman RJ 1998 Nutrition, aging, and reproduction in rhesus monkeys. In: Hansel W, Bray GA, Ryan DH, eds. Pennington Center Nutrition Series. Part IV. Evolution of research methods in nutrition and reproduction. Baton Rouge, LA: Louisiana State University Press; 180-195
39. Tiefenbacher S, Novak MA, Marinus LM, Chase WK, Miller JA, Meyer JS 2004 Altered hypothalamic-pituitary-adrenocortical function in rhesus monkeys (Macaca mulatta) with self-injurious behavior. Psychoneuroendocrinology 29:501-515
40. Dokmetas HS, Colak R, Kelestimur F, Selcuklu A, Unluhizarci K, Bayram F 2000 A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery. J Clin Endocrinol Metab [Erratum (2001) 86:3085] 85:3713-3719
41. Colak R, Kelestimur F, Unluhizarci K, Bayram F, Sahin Y, Tutus A 2002 A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17α enzyme activity in women with polycystic ovary syndrome. Eur J Endocrinol 147:473-477
42. Dumesic DA, Abbott DH, Eisner JR, Goy RW 1997 Prenatal exposure of female rhesus monkeys to testosterone propionate increases serum luteinizing hormone levels in adulthood. Fertil Steril 67:155-163
43. Dumesic DA, Schramm RD, Peterson E, Paprocki AM, Zhou R, Abbott DH 2002 Impaired developmental competence of oocytes in adult prenatally androgenized female rhesus monkeys undergoing gonadotropin stimulation for in vitro fertilization. J Clin Endocrinol Metab 87:1111-1119
44. Saltzman W, Schultz-Darken NJ, Scheffler G, Wegner FH, Abbott DH 1994 Social and reproductive influences on plasma cortisol in female marmoset monkeys. Physiol Behav 56:801-810
45. Eisner JR, Dumesic DA, Kemnitz JW, Colman RJ, Abbott DH 2003 Increased adiposity in female rhesus monkeys exposed to androgen excess during early gestation. Obes Res 11:279-286
46. Cohen HN, Wallace AM, Beastall GH, Fogelman I, Thomson JA 1981 Clinical value of adrenal androgen measurement in the diagnosis of delayed puberty. Lancet 1:689-692
47. Trainor BC, Marler CA 2001 Testosterone, paternal behavior, and aggression in monogamous California mouse (Peromyscus californicus). Horm Behav 40:32-42
48. Sokal RR, Rohlf FJ 1995 The principles and practice of statistics in biological research. 3rd ed. Biometry. New York: W. H. Freeman and Co; 413-422
49. Mesiano S, Jaffe RB 1997 Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev 18:378-403
50. Mapes S, Tarantal AF, Parker CR, Moran FM, Bahr JM, Pyter L, Conley AJ 2002 Adrenocortical cytochrome b5 expression during fetal development of the rhesus macaque. Endocrinology 143:1451-1458
51. Conley AJ, Pattison JC, Bird IM 2004 Variations in adrenal androgen production among (nonhuman) primates. Semin Reprod Med 22:311-326
52. Arlt W, Martens JW, Song M, Wang JT, Auchus RJ, Miller WL 2002 Molecular evolution of adrenarche: structural and functional analysis of p450c17 from four primate species. Endocrinology 143:4665-4672
53. Sklar CA, Kaplan SL, Grumbach MM 1980 Evidence for dissociation between adrenarche and gonadarche: studies in patients with idiopathic precocious puberty, gonadal dysgenesis, isolated gonadotropin deficiency, and constitutionally delayed growth and adolescence. J Clin Endocrinol Metab 51:548-556
54. Conley AJ, Bird IM 1997 The role of cytochrome P450 17 α-hydroxylase and 3 β-hydroxysteroid dehydrogenase in the integration of gonadal and adrenal steroidogenesis via the δ 5 and δ 4 pathways of steroidogenesis in mammals. Biol Reprod 56:789-799
55. Azziz R, Fox LM, Zacur HA, Parker CR, Boots LR 2001 Adrenocortical secretion of dehydroepiandrosterone in healthy women: highly variable response to adrenocorticotropin. J Clin Endocrinol Metab 86:2513-2517
56. Zhang LH, Rodriguez H, Ohno S, Miller WL 1995 Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Proc Natl Acad Sci USA 92:10619-10623
57. Payne AH, Hales DB 2004 Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev 25:947-970
58. Pattison JC, Abbott DH, Saltzman W, Nguyen AD, Henderson G, Ju H, Pryce CR, Allen AJ, Conley AJ, Bird IM 2005 Male marmoset monkeys express an adrenal fetal zone at birth, but not a zona reticularis in adulthood. Endocrinology 146:365-374